Authors:
Bignon, E
Bachy, A
Boigegrain, R
Brodin, R
Cottineau, M
Gully, D
Herbert, JM
Keane, P
Labie, C
Molimard, JC
Olliero, D
Oury-Donat, F
Petereau, C
Prabonnaud, V
Rockstroh, MP
Schaeffer, P
Servant, O
Thurneyssen, O
Soubrie, P
Pascal, M
Maffrand, JP
Le Fur, G
Citation: E. Bignon et al., SR146131: A new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I: In vitro studies, J PHARM EXP, 289(2), 1999, pp. 742-751
Authors:
Bignon, E
Alonso, R
Arnone, M
Boigegrain, R
Brodin, R
Gueudet, C
Heaulme, M
Keane, P
Landi, M
Molimard, JC
Olliero, D
Poncelet, M
Seban, E
Simiand, J
Soubrie, P
Pascal, M
Maffrand, JP
Le Fur, G
Citation: E. Bignon et al., SR146131: A new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II: In vivo pharmacological characterization, J PHARM EXP, 289(2), 1999, pp. 752-761
Authors:
Hoekstra, WJ
Maryanoff, BE
Damiano, BP
Andrade-Gordon, P
Cohen, JH
Costanzo, MJ
Haertlein, BJ
Hecker, LR
Hulshizer, BL
Kauffman, JA
Keane, P
McComsey, DF
Mitchell, JA
Scott, L
Shah, RD
Yabut, SC
Citation: Wj. Hoekstra et al., Potent, orally active GPIIb/IIIa antagonists containing a nipecotic acid subunit. Structure-activity studies leading to the discovery of RWJ-53308, J MED CHEM, 42(25), 1999, pp. 5254-5265